Shanghai Pharmaceuticals Holding (601607.SH) announced on Thursday its net profit attributable to shareholders reached 2.18 billion yuan in the first three quarters of this year, up 13.92 percent year on year.
Meanwhile, its operating turnover rose 15.02 percent year on year to 79.04 billion yuan.
In a breakdown, 8.88 billion yuan was contributed by pharmaceutical business, up 6.93 percent year on year; 69.82 billion yuan was from medicine distribution business, up 16 percent year on year; and 3.51 billion yuan was from drug retail sales business, up 14 percent year on year.
The operating profits from pharmacy, medicine distribution and drug retail sales reached 1.14 billion yuan, 1.91 billion yuan and 460 million yuan, respectively.
The company plans to strengthen the development of e-commerce subsidiary and provide online-to-offline drug purchasing experiences and medical services for customers.
Besides, it will expand investment in drug research and development to 6 percent of the total investment next year.
Latest comments